Owners
Aerie Pharmaceuticals is a pharmaceutical company dedicated to the discovery, development, manufacture and commercialization of first-in-class ophthalmic therapies.
History
2022: Alcon bought Aerie Pharmaceuticals for $753m
On August 23, 2022, it became known that contact lens manufacturer Alcon is acquiring glaucoma drug manufacturer Aerie Pharmaceuticals in a deal worth $753 million. Alcon is looking to strengthen its line of ophthalmic drugs, and the deal itself will close in the fourth quarter of 2022.
Alcon offered $15.25 per share, a premium of 37% to Aerie Pharmaceuticals' latest closing price. The value of the transaction was calculated on the basis of 49.36 million shares of Aerie Pharmaceuticals outstanding as of August 22, 2022. The Company intends to finance the acquisition through short-term and long-term borrowings.
The deal will add Rocklatan and Rhopressa eye drops from Aerie Pharmaceuticals to Alcon's portfolio, as well as a host of clinical and preclinical ophthalmic pharmaceutical candidates. Rocklatan eye drops combined eye drops are used alone or together with other drugs to reduce pressure inside the eye. Rhopressa to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Switzerland's Alcon, which was spun off from Novartis in 2019, said it expects the deal to increase its core earnings per share in 2024.
 | Aerie Pharmaceuticals is a natural combination with products already on the market and under development, as well as the R&D capabilities that provide the infrastructure needed to expand our ophthalmic pharmaceutical presence, Alcon Chief Executive Officer David Endicott said. |  |
Medical treatment of glaucoma is prescribed in the first stages of the disease. The doctor prescribes drops to reduce intraocular pressure, improve blood supply to the inner membranes of the eye and normalize metabolism in the tissues of the eye. After pressure normalization, the doctor prescribes maintenance therapy: injections of drugs, electrical stimulation.[1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |